Showing results (21-30 of 40) with videos related to
Sort By:
Pageof 4
Frontiers in Surgery|May 16, 2022
The Impact of Patient Deaths on General Surgeons' Psychosocial Well-Being and Surgical PracticesCihangir Akyol, Suleyman Utku Celik, Mehmet Ali Koc, et al.Journal of Oncology|September 21, 2020
Comparison of Involved Field Radiotherapy versus Elective Nodal Irradiation in Stage IIIB/C Non-Small-Cell Lung Carcinoma Patients Treated with Concurrent Chemoradiotherapy: A Propensity Score Matching StudyErkan Topkan, Yurday Ozdemir, Ozan Cem Guler, et al.Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|September 26, 2021
Double isocenter optimization with HD-MLC linear accelerator to treat extended fields in patients with head and neck cancersYucel Saglam, Ugur Selek, Yasemin Bolukbasi, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 15, 2023
Five-year overall survival with ipilimumab and stereotactic ablative radiotherapy for metastatic diseaseKewen He, David S Hong, Chad Tang, et al.Frontiers in Oncology|September 9, 2021
Pulsed Radiation Therapy to Improve Systemic Control of Metastatic CancerKewen He, Hampartsoum B Barsoumian, Duygu Sezen, et al.Cancers|January 11, 2022
High Plus Low Dose Radiation Strategy in Combination with TIGIT and PD1 Blockade to Promote Systemic Antitumor ResponsesHampartsoum B Barsoumian, Duygu Sezen, Hari Menon, et al.Frontiers in Immunology|October 24, 2022
Pulsed radiotherapy to mitigate high tumor burden and generate immune memoryDuygu Sezen, Hampartsoum B Barsoumian, Kewen He, et al.Journal of Nanobiotechnology|December 13, 2021
A radioenhancing nanoparticle mediated immunoradiation improves survival and generates long-term antitumor immune memory in an anti-PD1-resistant murine lung cancer modelYun Hu, Sébastien Paris, Hampartsoum Barsoumian, et al.Seminars in Radiation Oncology|June 6, 2021
Considerations for Clinical Trials Testing Radiotherapy Combined With Immunotherapy for Metastatic DiseaseDuygu Sezen, Vivek Verma, Kewen He, et al.Journal of Experimental & Clinical Cancer Research : CR|September 1, 2024
Novel engineered IL-2 Nemvaleukin alfa combined with PD1 checkpoint blockade enhances the systemic anti-tumor responses of radiation therapyKewen He, Nahum Puebla-Osorio, Hampartsoum B Barsoumian, et al.Pageof 4